# DESCRIPTION

## FIELD OF THE INVENTION

- introduce Grp94 as diagnostic marker

## STATE OF THE ART

- introduce glucose-regulated proteins
- describe Grp94 function
- discuss Grp94 role in tumors
- summarize Grp94 expression
- describe Grp94 translocation
- discuss Grp94 as cytokine
- summarize Grp94 in tumor development
- discuss Grp94 as therapeutic target
- describe Grp94-based vaccines
- discuss need for Grp94 detection
- criticize existing ELISA kits

## BACKGROUND AND AIM OF THE INVENTION

- introduce previous work on Grp94
- describe Grp94 in plasma of diabetic subjects
- discuss Grp94-IgG complexes
- describe non-immune binding of Grp94 and IgG
- summarize proteomic investigation
- discuss limitations of ELISA method
- introduce previous patent on Grp94-IgG complexes
- criticize previous ELISA method

## DETAILED DESCRIPTION OF THE INVENTION

- describe immunoassay for Grp94-IgG complexes
- introduce sandwich ELISA method
- detail primary antibody coating step
- describe washing step
- detail blocking solution step
- describe washing step
- add biological sample
- describe incubation step
- wash plate
- add secondary antibodies
- describe incubation step
- wash plate
- prepare substrate solution
- add substrate solution
- describe incubation step
- add stop solution
- evaluate colorimetric reaction
- describe experimental design
- detail patient selection criteria
- describe blood sample collection
- detail Western blot analysis
- describe ELISA method validation
- analyze plasma samples
- determine specificity and sensitivity
- analyze data by tumor type
- discuss results and implications

### DESCRIPTION OF THE FIGURES

- describe FIG. 1, sandwich ELISA scheme
- describe FIG. 2, Western blot analysis
- describe FIG. 3, ELISA measurements
- describe FIG. 4, ELISA measurements on multiple patients
- describe FIG. 5, ELISA measurements on patients and controls
- describe FIG. 6, ELISA measurements by tumor type
- summarize FIG. 1
- summarize FIG. 2
- summarize FIGs. 3-6

